NHS blood test detects more than 50 types of cancer before symptoms
Thousands of people will take part in the trial, due to start on Monday (13 September), to see how well the Galleri test works in the health service in the hope it could revolutionise cancer care in the UK.
It is being led by the Cancer Research UK and King’s College London Cancer Prevention Trials Unit together with Grail, which developed the blood test.
The Galleri test is currently available in the U.S. and can detect cancers that are not routinely screened for.
The blood test can pinpoint exactly where in the body the disease is coming from with a high degree of accuracy, which could help to improve early detection. ■